Johnson & Johnson (JNJ) — 10-Q Filings

10-Q Filings (6)

• J&J Q3 Earnings Soar 91% on Strong Sales, R&D Efficiency — Oct 22, 2025 Risk: medium
  Johnson & Johnson reported robust financial performance for the fiscal third quarter ended September 28, 2025, with sales to customers increasing by 6.77% to $2
• J&J Navigates Debt Landscape, Manages Shareholder Equity in Q2 — Jul 24, 2025 Risk: low
  Johnson & Johnson (JNJ) reported its Q2 2025 results for the period ending June 29, 2025. The company's financial statements indicate a stable capital structure
• J&J 10-Q: Debt Maturities and Financial Snapshot — Apr 23, 2025 Risk: low
  Johnson & Johnson filed its 10-Q for the period ending March 30, 2025. The filing details the company's financial position, including various debt instruments s
• Johnson & Johnson Q3 2024 10-Q Filing — Oct 23, 2024 Risk: low
  Johnson & Johnson filed its 10-Q for the period ending September 29, 2024. The filing details financial performance and operational updates for the third quarte
• Johnson & Johnson Q2 2024 10-Q Filed — Jul 25, 2024 Risk: low
  Johnson & Johnson filed its 10-Q for the period ending June 30, 2024. The company's fiscal year ends on December 29th. Key financial data and debt instruments,
• Johnson & Johnson Files 10-Q for Period Ending March 31, 2024 — May 1, 2024 Risk: medium
  JOHNSON & JOHNSON (JNJ) filed a Quarterly Report (10-Q) with the SEC on May 1, 2024. Johnson & Johnson filed a 10-Q report for the period ending March 31, 2024.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX